Whitehawk Therapeutics (WHWK) Enterprise Value (2010 - 2026)
Whitehawk Therapeutics (WHWK) reported Enterprise Value of -$123.0 million for Q1 2026, up 46.75% year-over-year from -$83.8 million in Q1 2025, and up 15.55% on a QoQ basis from -$145.7 million in Q4 2025.
Whitehawk Therapeutics (WHWK) has 17 years of Enterprise Value data on file, last reported at -$123.0 million in Q1 2026.
- Quarterly Enterprise Value rose 46.75% year-over-year to -$123.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$123.0 million (up 46.75% YoY) and the FY2025 annual result came in at -$145.7 million, down 208.44% from the prior year.
- Enterprise Value rose to -$123.0 million in Q1 2026 per WHWK's latest filing, from -$145.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$47.2 million in Q4 2024 and bottomed at -$287.3 million in Q3 2025.
- The 5-year median for Enterprise Value is -$129.8 million (2022), against an average of -$138.8 million.
- The widest annual swing landed in 2024, when Enterprise Value surged 56.6%; it then tumbled 358.75% in 2025.
- Tracing WHWK's Enterprise Value over 5 years: stood at -$172.6 million in 2022, then surged by 36.92% to -$108.8 million in 2023, then surged by 56.6% to -$47.2 million in 2024, then plunged by 208.44% to -$145.7 million in 2025, then gained by 15.55% to -$123.0 million in 2026.
- Per Business Quant, the three latest WHWK Enterprise Value figures stand at -$123.0 million (Q1 2026), -$145.7 million (Q4 2025), and -$287.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | -123.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -123.04 Mn |
| Dec 31, 2025 | -145.70 Mn |
| Sep 30, 2025 | -287.27 Mn |
| Jun 30, 2025 | -177.20 Mn |
| Mar 31, 2025 | -231.06 Mn |
| Dec 31, 2024 | -47.24 Mn |
| Sep 30, 2024 | -62.62 Mn |
| Jun 30, 2024 | -78.57 Mn |
| Mar 31, 2024 | -88.27 Mn |
| Dec 31, 2023 | -108.85 Mn |
| Sep 30, 2023 | -119.34 Mn |
| Jun 30, 2023 | -134.89 Mn |
| Mar 31, 2023 | -151.17 Mn |
| Dec 31, 2022 | -172.56 Mn |
| Sep 30, 2022 | -183.01 Mn |
| Jun 30, 2022 | -118.74 Mn |
| Mar 31, 2022 | -129.80 Mn |
| Dec 31, 2021 | -148.99 Mn |
| Sep 30, 2021 | -161.38 Mn |
| Jun 30, 2021 | -36.82 Mn |
| Mar 31, 2021 | -39.01 Mn |
| Dec 31, 2020 | -4.46 Mn |
| Sep 30, 2020 | -47.28 Mn |
| Jun 30, 2020 | -44.86 Mn |
| Mar 31, 2020 | -34.58 Mn |
| Dec 31, 2019 | -38.52 Mn |
| Sep 30, 2019 | -43.39 Mn |
| Jun 30, 2019 | -48.16 Mn |
| Mar 31, 2019 | -53.42 Mn |
| Dec 31, 2018 | -62.61 Mn |
| Sep 30, 2018 | -68.81 Mn |
| Jun 30, 2018 | -68.78 Mn |
| Mar 31, 2018 | -13.76 Mn |
| Dec 31, 2017 | -20.26 Mn |
| Sep 30, 2017 | -24.88 Mn |
| Jun 30, 2017 | -28.90 Mn |
| Mar 31, 2017 | -35.19 Mn |
| Dec 31, 2016 | 72.10 Mn |
| Sep 30, 2016 | -1.31 Mn |
| Jun 30, 2016 | -1.60 Mn |
| Mar 31, 2016 | -1.16 Mn |
| Dec 31, 2015 | 65.34 Mn |
| Sep 30, 2015 | -6,270.00 |
| Jun 30, 2015 | -10,095.00 |
| Mar 31, 2015 | -23,287.00 |
| Dec 31, 2014 | -5,263.00 |
| Sep 30, 2014 | -17,868.00 |
| Jun 30, 2014 | -4,568.00 |
| Mar 31, 2014 | -5,883.00 |
| Dec 31, 2013 | -6,283.00 |
| Sep 30, 2013 | -10,295.00 |
| Jun 30, 2013 | -2,706.00 |
| Mar 31, 2013 | -2,706.00 |
| Dec 31, 2012 | -4,607.00 |
| Sep 30, 2012 | -5,391.00 |
| Jun 30, 2012 | -9,311.00 |
| Mar 31, 2012 | -23,598.00 |
| Dec 31, 2011 | -4,125.00 |
| Sep 30, 2011 | -6,130.00 |
| Jun 30, 2011 | -9,230.00 |
| Mar 31, 2011 | -24,634.00 |
| Dec 31, 2010 | -26,898.00 |
| Sep 30, 2010 | -2,254.00 |